Randall Friese, MD, and Rein Anton, MD, PhD, will lead the study, examining a new drug designed to protect and regenerate spinal nerves after acute spinal cord injury. Patients must be treated within 12 hours of injury and medication is given for 28 days, according to the report.
Patients are randomized either to receive the drug or a placebo.
More articles on spine surgery:
Orthopedist vs. neurosurgeon for elective spine surgeries: Does it make a difference?
Spine Team Texas wins LIVING magazine’s Reader’s Choice award
21 spine, neurosurgeons on the move
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.